Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 269 No 7222 p636
2 November 2002

This article
Reprint
Photocopy


News summary

Related websites
BMJ (bmj.com)


Alternative to penicillin for erysipelas

Pristinamycin, an antimicrobial active against Streptococcus pyogenes, could be an alternative to a regimen of intravenous and then oral penicillin for the treatment of erysipelas, an acute superficial cellulitis, researchers report.

After 14 days of treatment, the cure rate was 81 per cent with pristinamycin (n=102) and 67 per cent with penicillin (n=102) (BMJ 2002;325:864).

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal